Researchers in Ireland have taken a major step forward in the battle against medical implant infections. They developed a new type of implant scaffold to provide localized drug treatment and prevent infection, which has already proven effective against two types of major problem bacteria.
Publishing their results today in the journal Biomedical Materials, the team from the National University of Ireland Galway show that stabilized collagen scaffolds loaded with a particular antibiotic were able to prevent both Escherichia coli and Staphylococcus epidermidis from forming.
Lead author Dr. Dimitrios Zeugolis, from NUI Galway's Regenerative, Modular & Developmental Engineering Laboratory (REMODEL) and Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), said: Implant infections remain a major healthcare problem. They can require long hospitalization periods to disturb and treat bacterial biofilm formation. There can also be a need for additional surgeries to remove or replace the infected implant, which if not done in time may lead to sepsis.
"Although localized drug treatment, via an implanted scaffold has shown promise, the ideal scaffold cross-linking (to initially withstand the aggressive infection environment) and drug (to fight against infection) have not, until now, been found."
The team first developed a collagen scaffold, with a 0.625 per cent concentration of hexamethylene diisocyanate (HDI) used to stabilize it. They then tested the scaffolds with variable concentrations of the antibiotics Cefaclor and Ranalexin.
Zeugolis said: "Both drugs showed similar loading efficiency, release profile and cytocompatibility. However, only collagen scaffolds loaded with 100 μg/ml of Cefaclor showed adequate antibacterial properties against both E-coli and Staphylococcus epidermidis.
"Our cross-linked collagen scaffold marks an important step forward against a problem that is both a major health problem and a severe economic burden to healthcare systems internationally."
Source: IOP Publishing
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.